434197864 | PUO | 41085865 | | 9410463 | 2/7/2007 12:00:00 AM | Asthma flair | | DIS | Admission Date: 10/7/2007 Report Status: 

Discharge Date: 8/26/2007 ****** FINAL DISCHARGE ORDERS ****** TROWERY , DEDE C 032-72-55-8 Norf Service: MED DISCHARGE PATIENT ON: 7/11/07 AT 05:00 PM CONTINGENT UPON Not Applicable WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: VACEK , WALTON JANELLA , M.D. , M.P.H. CODE STATUS: Full code DISPOSITION: Home MEDICATIONS ON ADMISSION: 1. ALBUTEROL AND IPRATROPIUM NEBULIZER 3/0.5 MG NEB Q4H 2. ALBUTEROL NEBULIZER 2.5 MG NEB Q2H 3. DIVALPROEX SODIUM 500 MG PO BID 4. DOCUSATE SODIUM 100 MG PO BID 5. HYDROCHLOROTHIAZIDE 12.5 MG PO QD 6. INSULIN NPH HUMAN 26 UNITS SC BID 7. INSULIN REGULAR HUMAN 10 UNITS SC BID 8. LACTULOSE 15-30 MILLILITERS PO QID 9. LISINOPRIL 20 MG PO QD 10. OXYCODONE 10 MG PO Q4H 11. 
PREDNISONE 60 MG PO QD 12. RISPERIDONE 3 MG PO QD 13. SENNOSIDES 2 TAB PO BID 14. 
TRAZODONE 300 MG PO HS 15. 
ABILIFY 15 MG PO QHS 16. INSULIN SYRINGES 1 CC SC BID 17. ONE TOUCH ULTRA SOFT LANCETS 18. ONE TOUCH ULTRA TEST STRIPS MEDICATIONS ON DISCHARGE: ALBUTEROL AND IPRATROPIUM NEBULIZER 3/0.5 MG NEB Q4H ALBUTEROL NEBULIZER 2.5 MG NEB Q2H ZYRTEC ( CETIRIZINE ) 10 MG PO DAILY Food/Drug Interaction Instruction Avoid grapefruit unless MD instructs otherwise. 
DEPAKOTE ( DIVALPROEX SODIUM ) 500 MG PO BID COLACE ( DOCUSATE SODIUM ) 100 MG PO BID PEPCID ( FAMOTIDINE ) 20 MG PO DAILY Alert overridden: Override added on 8/10/07 by : POTENTIALLY SERIOUS INTERACTION: OMEPRAZOLE &amp; FAMOTIDINE Reason for override: Omeprazole discontinued FLONASE NASAL SPRAY ( FLUTICASONE NASAL SPRAY ) 2 SPRAY NA DAILY Instructions: 2 sprays in each nostril once a day ADVAIR DISKUS 500/50 ( FLUTICASONE PROPIONATE/... ) 1 PUFF INH BID HYDROCHLOROTHIAZIDE 12.5 MG PO DAILY INSULIN NPH HUMAN 28 UNITS SC BID Starting Today February HOLD IF: If not eating take half dose INSULIN REGULAR HUMAN 10 UNITS SC BID LACTULOSE 30 MILLILITERS PO QID PRN Constipation LISINOPRIL 20 MG PO DAILY Override Notice: Override added on 11/19/07 by LENEAVE , JETTA , M.D. on order for KCL IMMEDIATE RELEASE PO ( ref # 771039577 ) POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE Reason for override: will monitor OXYCODONE 10 MG PO Q4H PRN Pain PREDNISONE Taper PO Give 60 mg q 24 h X 2 dose( s ) , then Give 40 mg q 24 h X 3 dose( s ) , then Give 20 mg q 24 h X 3 dose( s ) , then Starting Today November RISPERDAL ( RISPERIDONE ) 3 MG PO DAILY SENNA TABLETS ( SENNOSIDES ) 2 TAB PO BID TRAZODONE 300 MG PO BEDTIME ABILIFY 15 MG PO BEDTIME DIET: House / Low chol/low sat. 
fat DIET: House / ADA 1800 cals/dy ACTIVITY: Resume regular exercise FOLLOW UP APPOINTMENT( S ): Dr. Flo Titterness PCP phone 041-877-2543 11/1 at noon scheduled , Dr. Chilo Psych 6/12 at 10am scheduled , Dr. Bedatsky Pulmonology phone 947-164-2074 10/25 at 1pm scheduled , Pulmonary Function Testing phone 588.572.8489 10/25 at 11am scheduled , ALLERGY: Aspirin , NSAIDs , Penicillins , ACETAMINOPHEN ADMIT DIAGNOSIS: asthma PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) Asthma flair OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay NSVD x 4 Asthma , s/p ~15 intubations ( asthma ) diabetes ( ) vocal cord dysfunction-Addunction syndrome schizoaffective disorder bipolar subtype morbid obesity ( obesity ) HTN ( hypertension ) Sleep Apnea OPERATIONS AND PROCEDURES: see discharge summary OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) see discharge summary BRIEF RESUME OF HOSPITAL COURSE: CC: SOB HPI: 33 yo F with history of asthma s/p 15 intubations who was discharged on 11/23/07 after a 5 days hospitalization for an asthma flair. 
The patient reports that she was fine at home initially but that by Saturday evening approx 2:30AM , she noted worsening SOB and gradual onset of CP. 
The pain in her chest was diffuse approx 9/10 in severity without radiation and worse with movement or inspiratory effort. 
The SOB did not abate despite constant albuterol nebs and taking her dose of Prednisone 60mg that morning. 
She reports that her peak flow was 300 at home and in the ED. 
Her baseline is 500. 
Consequently , she decided to return to the PUO ED. 
In the short interim since her discharge she reports being compliant with all of her medications. 
She stayed at home during this interval without any clear precipitating trigger including exertion , cold air , URI , respiratory irritants such as cleaning products or perfumes or significant emotional stress. 
She recently had her carpets cleaned. 
PMH: 1. Asthma , s/p 15 intubations , Last intubation last year , since age 12 , 10+ flares/year requiring steroids. 
( 2005 PFT FEV1 90s , FVC 90 , FEV/FVC90 ) 2. HTN 3. IDDM 4. Schizoaffective d/o bipolar subtype 5. Morbid obesity 6. laryngeal adduction syndrome 7. TTE: EF 60% 2005 PSH 1. Appendectomy 2003 2. C-section 1997 ALL: NSAIDs , ASA - angioedema , Tylenol - hives , PCN - hives Meds on Admission: DUONEB 3/0.5 MG Q4H , ALBUTEROL 2.5 MG Q2H PRN SOB , Wheezing , DEPAKOTE 500Mg BID , HCTZ 12.5 MG qd , LISINOPRIL 20 MG qd , OXYCODONE 10MG Q4H PRN Pain , PREDNISONE 60MG qd taper , RISPERDAL 3MG qd , INSULIN NPH HUMAN 26 UNITS BID , INSULIN REGULAR HUMAN 10 UNITS BID , LACTULOSE 15-30ML QID PRN Constipation , TRAZODONE 300MG qHS , ABILIFY 15 MG qHS , Pepcid 20mg qd , Senna/Colace Meds on Discharge DUONEB 3/0.5 MG Q4H , ALBUTEROL 2.5 MG Q2H PRN SOB , Wheezing , DEPAKOTE 500Mg BID , HCTZ 12.5 MG qd , LISINOPRIL 20 MG qd , OXYCODONE 10MG Q4H PRN Pain , PREDNISONE 60MG qd taper , RISPERDAL 3MG qd , INSULIN NPH HUMAN 26 UNITS BID , INSULIN REGULAR HUMAN 10 UNITS BID , LACTULOSE 15-30ML QID PRN Constipation , TRAZODONE 300MG qHS , ABILIFY 15 MG qHS , Pepcid 20mg qd , Senna/Colace , Singulair 10mg qd , Advair INH 500/50 BID , Zyrtec 10mg qd , Flonase Nasal Spray 2 puffs in each nostril qd Physical Exam Tm/c 97.9/97.1 
HR 85-95 BP 94-114/50-60 RR 18 O2Sat 99% RA General: Morbidly obese woman lying comfortably in bed able to speak in full sentences HEENT: NCAT. 
PERRLA at 3mm , VFFC , sclera anicteric. 
Oropharynx is clear without erythema , exudates or lesions. 
Mucous membranes moist Neck: No LAD noted. 
Trachea midline , no carotid bruits appreciated. 
Thyroid not enlarged and without nodules. 
Heart: RRR. 
nl S1 and S2 , no MGR. 
JVP is 5cm Pulm: Distant breath sounds equal b/l. 
No wheezes were heard. 
Not using accessory muscles for respiration. 
Abd: NTND , NABS. 
No masses. 
No HSM. 
Well healed surgical scar. 
Spine/Ext: No vertebral or paravertebral tenderness appreciated. 
DPs are 2+ throughout with no CCE Neuro: CN II-XII intact. 
Motor -5/5 throughout. 
Sensation: Symmetric to PP , temp and vibration throughout. 
Proprioception is intact. 
Coordination is unremarkable. 
DTRs 2+ throughout. 
MS AOx 3. Imaging 1. Chest radiograph: normal study unchanged from patient's previous studies 2. PE CT: suboptimal study due to obesity. 
No evidence of central PE or large DVT. 
Hospital Course: 1.	Pulm: H/o severe asthma with recent asthma flare , readmitted after one day at home with worsneing SOB despite being on Prednisone 60mg qd and Albuteral Nebs. 
Acutely in the ED , the patient was stable without significant wheezing , tachypnea , low 02 sats , use of accessory muscles for inspiration. 
CXR clear. 
Triggers were reviewed with the patient. 
There were no clear precipitating triggers to this flare other than carpet cleaning at home. 
On the floor , the patient received solumedrol x 1 dose then was transitioned back to prednisone. 
Breath sounds were diminished but no wheezing was evident. 
She was continued on duoneb and albuterol nebulizers for SOB. 
Singulair was added to her medication regimen for maximum possible pharmacological coverage. 
The patient's outpatient pulmonologist was consulted , recommended continued CPAP and outpatient follow up including PFTs. 
Peak flows improved from 300 to 530 on Hospital day 3. Arrangements were made for her to have CPAP at home and for outpatient Pulmonary follow up. 
She will start zyrtec and flonase for possible allergic component to asthma. 
On hospital day 2 , her PPD was read as negative. 
2.	CV: The patient was continued on Lisinopril and HCTZ for BP control. 
Her JVP was not elevated. 
A routine EKG showed no changes from previous exam and nothing to suggest cardiac ischemia. 
CP appeared musculoskeletal in origin and the patient was maintained on oxycodone for pain control. 
3.	GI: The patient's bowel regimen was continued for constipation , and will be continued at discharge. 
4.	Psych: We continued all home meds for treatment of her schizoaffective disorder. 
An appointment for outpatient follow up was made with her psychiatrist Dr. Chilo . 
5.	FEN: The patient was stable. 
ADA diet. 
Replete K and MG 6.	PPX: Lovenox was used for DVT prophylaxis while an inpatient but was discontinued on discharge. 
She should remain on a PPI while on steroids 7.	Code: full 8.	Dispo: home Of note , patient left the hospital prior to receiving discharge paperworka nd prescriptions. 
ADDITIONAL COMMENTS: Your medications have been changed in the following ways: 1. ) You have 3 new medications: Zyrtec to take once a day , flonase nasal spray once a day , and pepcid to take twice a day. 
2. ) Your NPH has been increased from 26 units to 28 units per day. 
You will need to follow up with your PCP for further adjustments. 
3. ) Continue the prednisone taper that you have at home. 
4. ) While on oxycodone , you should take a strong bowel regimen to prevent constipation including colace and lactulose. 
5. ) Continue all other home medications as prescribed. 
*Please follow up with Dr. Bedatsky . 
Obtain pulmonary function tests as scheduled prior to your appointment , *Please seek medical attention for difficulty breathing , chest pain , fever , worsening cough , or any other concerns. 
DISCHARGE CONDITION: Stable TO DO/PLAN: 1. 
The patient has been instructed to resume her Advair inhaler while she finishes her oral steroid taper. 
2. Pulmonology: Appt with Dr. Bedatsky . 
Full PFTs scheduled prior to visit. 
Please make recommendations for disease management. 
3. PCP: Follow up patient after steroid taper. 
Management of DM and HTN. 
Please emphasize the need for weight-loss and life style modification. 
4. Psych Please manage schizoaffective disorder. 
Please consider ativan prn for anxiety. 
Since we consider anxiety to a be a possible trigger of the patient's respiratory problems. 
No dictated summary ENTERED BY: LENEAVE , JETTA , M.D. ( KQ022 ) 7/11/07 @ 04:05 PM ****** END OF DISCHARGE ORDERS ******